Orthofix Medical (OFIX) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $13.00 from $18.00 | Aug 10, 2026 |
| Barrington Research | Maintained | Outperform | $17.00 from $15.00 | Jul 6, 2026 |
| Stifel | Maintained | Buy | $15.00 from $18.00 | May 22, 2026 |
| Barrington Research | Maintained | Outperform | $15.00 from $17.00 | May 22, 2026 |
| Canaccord Genuity | Maintained | Buy | $18.00 from $20.00 | May 22, 2026 |
| Barrington Research | Maintained | Outperform | $17.00 | Apr 10, 2026 |
| Stifel | Maintained | Buy | $18.00 from $22.00 | Mar 9, 2026 |
| Canaccord Genuity | Maintained | Buy | $20.00 from $24.00 | Feb 26, 2026 |
| Barrington Research | Maintained | Outperform | $17.00 from $18.00 | Feb 25, 2026 |
| Barrington Research | Maintained | Outperform | $18.00 | Feb 17, 2026 |
| TD Cowen | Initiated Coverage | Hold | $14.00 | Jan 27, 2026 |
| Barrington Research | Maintained | Outperform | $18.00 from $17.00 | Nov 5, 2025 |
| Stifel | Maintained | Buy | $22.00 | Oct 28, 2025 |
| Barrington Research | Maintained | Outperform | $17.00 | Oct 23, 2025 |
| Barrington Research | Maintained | Outperform | $17.00 | Sep 23, 2025 |
| Barrington Research | Initiated Coverage | Outperform | $16.00 | Jun 23, 2025 |
| JMP Securities | Maintained | Market Perform | — | Jun 6, 2025 |
| Roth MKM | Maintained | Buy | $22.00 | Feb 26, 2025 |
| Canaccord Genuity | Maintained | Buy | $24.00 | Feb 26, 2025 |
| Canaccord Genuity | Initiated Coverage | Buy | $24.00 | Jan 22, 2025 |
Frequently asked questions
Is OFIX a buy, sell, or hold?
Analysts covering Orthofix Medical currently average a Buy rating: 3 buy, 2 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on OFIX?
On Aug 10, 2026, Canaccord Genuity maintained Orthofix Medical at Buy with a price target of $13.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.